Anti-Cancer CAS 302962-49-8 Dasatinib Powder Dasatinib

Dasatinib (CAS number 302962-49-8) is an oral tyrosine kinase inhibitor small molecule targeted drug. It is a white to off white powder and belongs to the class of amino pyrimidine derivatives in terms of chemical structure. This product is prepared through high-precision synthesis and purification processes, and must comply with strict pharmacopoeial standards (such as USP, ChP) to ensure high purity and quality stability in key indicators such as content, related substances, and residual solvents. It is mainly used for the preparation of anti-tumor preparations.

Dasatinib is an orally administered agent that exerts its therapeutic effects by targeting specific signaling pathways involved in the proliferation and survival of abnormal cells. It binds to relevant molecular targets to inhibit their activity and block the growth signals that drive the uncontrolled division of affected cells. It is widely used in the clinical management of specific conditions, helping to control disease-related symptoms, improve the clinical status of patients, and enhance their quality of life. Its oral formulation offers convenience for long-term administration.